Increased frequency of MEFV gene mutations in patients with primary dysmenorrhea

  title={Increased frequency of MEFV gene mutations in patients with primary dysmenorrhea},
  author={Ş{\"u}kran Erten and Alpaslan Altunoğlu and H{\"u}seyin Levent Keskin and G{\"u}lay G{\"u}leç Ceylan and A C Yazici and Ahmet Ferit Dalgacı and G{\"o}khan Uyanik and Ayşe Filiz Yavuz Avşar},
  journal={Modern Rheumatology},
  pages={959 - 962}
Abstract Objectives Familial Mediterranean fever (FMF) is an autoinflammatory disease characterized by recurrent attacks of fever and polyserositis and an autosomal recessive inheritance mode. Up to 15 % of FMF patients are reported to experience perimenstrual attacks. Primary dysmenorrhea could be an incomplete abdominal attack, or patients with dysmenorrhea may have increased frequency of MEFV gene mutation carriage. Therefore, we aimed to evaluate the frequency of MEFV gene mutations in… 
1 Citations
Diagnostic value of oxidative stress markers in patients presenting with primary dysmenorrhea to the emergency department
PD is characterized by increased oxidative stress and ischemia in the endometrium, which can be detected by TDH parameters and serum IMA, which suggests IMA level can be valuable to determine the severity of endometrial ischemIA and pain in patients with PD.


Association of familial Mediterranean fever-related MEFV variations with ankylosing spondylitis.
FMF-related MEFV variations are associated with AS, and these variations may contribute to the pathogenesis of AS, especially in populations in which the prevalence of FMF is high.
The spectrum of MEFV clinical presentations--is it familial Mediterranean fever only?
Findings suggest that the MEFV gene is associated with clinical conditions other than FMF and its link to such clinical phenotypes may call for a higher awareness of the existence of additional autoinflammatory diseases.
Changing concepts in familial Mediterranean fever: is it possible to have an autosomal-recessive disease with only one mutation?
  • S. Ozen
  • Medicine, Biology
    Arthritis and rheumatism
  • 2009
Familial Mediterranean fever patients with only 1 MEFV mutation may produce a disease Seza Özen, MD: Hacettepe University, Ankara, Turkey, and routine screening for the common mutations is adequate in the clinical setting.
Familial Mediterranean fever. A survey of 470 cases and review of the literature.
Familial Mediterranean Fever (FMF) in Turkey: Results of a Nationwide Multicenter Study
The features of the disease in the Turkish population are described and it is shown that amyloidosis is still a substantial problem, even among the 18 patients with a disease onset after age 40 years.
The relations between attacks and menstrual periods and pregnancies of familial Mediterranean fever patients
Although FMF attacks and discomforts of menstrual cycles do overlap frequently, patients can easily differentiated them and patients can be reasonably assured that the period of pregnancy will be comfortable but abstaining from colchicine should not be recommended.
Therapeutic approach to familial Mediterranean fever: a review update.
Familial Mediterranean fever (FMF) is a hereditary disorder characterised by recurrent attacks of fever with peritonitis or pleuritis, arthritis, myalgia or erysipelas-like skin lesions. The
Familial Mediterranean fever.
Familial Mediterranean Fever is a genetically determined disease occurring predominantly in Arabs, Armenians, Jews and very rarely in Turks, and is virtually devoid of untoward side effects, even in pregnancy and childhood.
Treatment of primary and secondary dysmenorrhea with a novel 'frameless' intrauterine levonorgestrel-releasing drug delivery system: a pilot study
The results of this preliminary study suggest that the FibroPlant-LNG IUS, releasing 14 μg of LNG per day, is a safe and effective method for the treatment of primary and secondary dysmenorrhea, and the absence of a frame is particularly advantageous in these women.
Reproductive system in familial Mediterranean fever: an overview
Overall, colchicine treatment improves the prognosis of patients with FMF and increases their reproductive ability and may prevent the development of amyloidosis.